Associations between complete remission and 2- to 3-year survival following 7 + 3 induction for acute myeloid leukemia

Megan Othus, Guillermo Garcia-Manero, John Godwin, James Weick, Derek Stirewalt, Frederick Appelbaum, Harry Erba, Elihu Estey

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Among acute myeloid leukemia (AML) patients treated with 7 + 3 induction, we evaluate the association between complete morphologic remission (CR) and long-term overall survival (OS) over four decades. We analyzed 1247 patients age (Formula presented.) 65 randomized to 7 + 3 arms from five SWOG studies. OS has improved over the four decades. Hazards for death in the two most recent studies fell after year 2. In multivariable models, decade of therapy was the most important variable with respect to long-term survival and CR by day 100 the second most important variable. Protocol/decade, which captures many factors not included in our multivariable model, was the most important predictor of being alive at year 2 or 3. The next most important factor was achievement of first CR by day 100.

Original languageEnglish (US)
Pages (from-to)1967-1972
Number of pages6
JournalLeukemia and Lymphoma
Volume62
Issue number8
DOIs
StatePublished - 2021

Keywords

  • Acute myeloid leukemia
  • complete remission
  • induction
  • overall survival

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Associations between complete remission and 2- to 3-year survival following 7 + 3 induction for acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this